Real-World Depression Screening Practices Among Primary Care Providers Across Patient-Level and Provider-Level Characteristics

被引:0
|
作者
Bruni, Teryn [1 ,2 ,9 ]
Smith, Shawna [3 ]
Quigley, Joanna [4 ]
Koval, Elizabeth [5 ]
Lalonde, Leah [6 ]
Maragakis, Alexandros [7 ]
Kilbourne, Amy M. [7 ,8 ]
King, Cheryl [4 ]
Orringer, Kelly [1 ]
Lee, Joyce M. [1 ]
机构
[1] Univ Michigan, Dept Pediat, Michigan Med, Ann Arbor, MI USA
[2] Algoma Univ, Dept Psychol, Sault Ste Marie, ON, Canada
[3] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI USA
[4] Michigan Med, Child & Adolescent Psychiat, Ann Arbor, MI USA
[5] Cent Michigan Univ, Mt Pleasant, MI USA
[6] Eastern Michigan Univ, Dept Psychol, Ypsilanti, MI USA
[7] Amer Coll Greece, Dept Psychol, Athens, Greece
[8] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA
[9] Algoma Univ, Dept Psychol, 1520 Queen St East, Sault Ste Marie, ON P6A2G4, Canada
基金
美国国家卫生研究院;
关键词
primary care; follow-up; depression; screening; adolescent health/medicine; ADOLESCENT DEPRESSION; HEALTH-PROBLEMS; IDENTIFICATION; OUTCOMES; CHILDREN;
D O I
10.1177/00099228231223782
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
This study examined primary care provider (PCP) alignment with guideline-based care for adolescent depression screening and identified factors associated with post-screening responses. A retrospective chart review was conducted across 17 primary care clinics. Logistical regressions were estimated across provider specialties, sociodemographic factors, and patient clinical histories. Significant differences in follow-up and identification of depression were found among patients with more severe depression presentation. Follow-up screening was also more likely to be completed among patients with private insurance and less likely to occur among Black patients. Patients with significant mental health history of a mood concern, history of being prescribed psychotropic medication, were currently on medications at the time of the screening, or had a history of an internal mental health referral had a higher predicted probability of being identified as depressed on the patient problem list.
引用
收藏
页码:1442 / 1451
页数:10
相关论文
共 38 条
  • [31] Patient, provider, and practice level factors associated with ATP III LDL-cholesterol goal attainment in primary care practices: Baseline results of the Cholesterol Education and Research Trial
    Eaton, CB
    Parker, D
    Roberts, M
    Ahern, D
    Lu, B
    CIRCULATION, 2006, 113 (08) : E329 - E330
  • [32] Predicting non-response to ketamine for depression: an exploratory symptom-level analysis of real-world data among military veterans (vol 335 115858, 2024)
    Miller, Eric A.
    Afshar, Houtan Totonchi
    Mishra, Jyoti
    McIntyre, Roger S.
    Ramanathan, Dhakshin
    PSYCHIATRY RESEARCH, 2024, 339
  • [33] Applying Artificial Intelligence Machine Learning to Discover Factors That Shorten Duration of Treatment in Patients with Multiple Myeloma Using Real-World Patient-Level Longitudinal Data from Medical Data Vision Database
    Handa, Hiroshi
    Ishida, Tadao
    Ozaki, Shuji
    Iida, Shinsuke
    Mori, Asuka
    Sakai, Chika
    Kato, Kenichi
    Wu, David Bin-Chia
    Yu, DaeYoung
    Nemoto, Shota
    Yamashita, Yasuho
    Shibahara, Takuma
    BLOOD, 2023, 142
  • [34] What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study's patient-level data with fidelity to the original research protocol
    Pigott, H. Edmund
    Kim, Thomas
    Xu, Colin
    Kirsch, Irving
    Amsterdam, Jay
    BMJ OPEN, 2023, 13 (07):
  • [35] DEVELOPMENT AND VALIDATION OF PATIENT-LEVEL PREDICTION MODELS FOR ADVERSE HEALTH OUTCOMES AMONGST ADULT RA PATIENTS INITIATING FIRST-LINE TREATMENT OF METHOTREXATE MONOTHERAPY: A MULTINATIONAL REAL-WORLD COHORT ANALYSIS INCLUDING 164,735 SUBJECTS
    Yang, C.
    Williams, R.
    Swerdel, J.
    Jani, M.
    Duarte-Salles, T.
    Chatzidionysiou, K.
    Prieto-Alhambra, D.
    Ryan, P.
    Rijnbeek, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 134 - 134
  • [36] AN EXPLORATORY ANALYSIS OF REAL-WORLD DATA FOR ASSESSING PATIENT CHARACTERISTICS, REGION, STAGE, AND PD-L1 HEALTH-CARE UTILIZATION AMONG US PATIENTS WITH ADVANCED LUNG CANCER
    Amato, G.
    LaVallee, C.
    Thompson, C.
    Mushtaq, M.
    VALUE IN HEALTH, 2023, 26 (06) : S384 - S384
  • [37] REAL-WORLD PATIENT CHARACTERISTICS AND PATTERNS OF CARE AMONG METASTATIC UROTHELIAL, HEAD AND NECK, NON-SMALL CELL LUNG CANCER PATIENTS USING A GERMAN SICKNESS FUND CLAIMS DATABASE
    Klein, A. B.
    Shire, N.
    Winget, M.
    Wang, H.
    Wilk, A.
    Pignot, M.
    VALUE IN HEALTH, 2017, 20 (09) : A473 - A473
  • [38] Center-Level and Socioeconomic Variation in Patient Health Questionnaire-9 (PHQ-9) Depression Scores: Real-World Evidence from the Multiple Sclerosis Continuous Quality Improvement (MS-CQI) Research Collaborative Study (2017-2020)
    Nguyen, J. A.
    Yang, A. A.
    Walsh, K. A.
    Mehta, F. S.
    Oliver, B. J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 198 - 198